期刊中文名:當(dāng)前心血管影像報(bào)告ISSN:1941-9066E-ISSN:1941-9074
該雜志國(guó)際簡(jiǎn)稱(chēng):CURR CARDIOVASC IMAG,是由出版商Springer Nature出版的一本致力于發(fā)布--研究新成果的的專(zhuān)業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專(zhuān)論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。
《Current Cardiovascular Imaging Reports》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱(chēng)當(dāng)前心血管影像報(bào)告,本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為0.6,最新CiteScore 指數(shù)為2.2。
cardiovascular Imaging Technologies Now Play An Expanded Role In Clinical Practice. Beyond The Diagnosis Of A Disease Process, These Techniques Are Rapidly Transitioning To Help Guide Therapy. The Journal Aims To Keep Readers Current With Rapidly Evolving Advances In Instrumentation And Imaging Procedures That Support The Expanded Role Of These Technologies In Clinical Practice. The Journal Intends To Place The Entire Area Of Cardiovascular Imaging In Its Proper Prospective By Establishing The Indications And Limitations Of Each Imaging Technique And By Summarizing Recent Clinical Advances.
we Accomplish This Aim By Appointing International Authorities To Serve As Section Editors In Key Subject Areas Across The Field, Including Cardiac Magnetic Resonance, Nuclear Imaging, Echocardiography, Cardiac Computed Tomography, Intravascular, Molecular, And Hybrid Imaging. Section Editors Select Topics For Which Leading Experts Contribute Comprehensive Review Articles That Emphasize New Developments And Recently Published Papers Of Major Importance, Highlighted By Annotated Reference Lists. An Editorial Board Of Internationally Diverse Members Ensures That Topics Include Emerging Research And Suggests Topics Of Special Interest To Their Country/region. We Also Provide Commentaries From Well-known Figures In The Field.
按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q4
排名:184 / 204
百分位:
10% |
按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q4
排名:169 / 204
百分位:
17.4% |
JCR分區(qū):JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類(lèi)按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
學(xué)科類(lèi)別 | 分區(qū) | 排名 | 百分位 |
大類(lèi):Medicine 小類(lèi):Histology | Q3 | 44 / 62 |
29% |
大類(lèi):Medicine 小類(lèi):Applied Microbiology and Biotechnology | Q3 | 92 / 127 |
27% |
大類(lèi):Medicine 小類(lèi):Cell Biology | Q4 | 249 / 285 |
12% |
該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在綜合專(zhuān)業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。